Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Jupiter Wellness Inc
(NQ:
JUPW
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 14, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Jupiter Wellness Inc
< Previous
1
2
3
4
5
6
Next >
Jupiter Wellness Announces JW-300 Clinical Trial Results
November 16, 2021
JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial. JUPITER, FL / ACCESSWIRE / November 16, 2021 / Jupiter Wellness, Inc....
From
Jupiter Wellness, Inc.
Via
AccessWire
NASDAQ Company Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema (NASDAQ: JUPW) Jupiter Wellness
November 11, 2021
Via
Get News
Jupiter Wellness Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema
November 11, 2021
JUPITER, FL / ACCESSWIRE / November 11, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing cannabinoid receptor agonists for the treatment of eczema, actinic keratosis,...
From
Jupiter Wellness, Inc.
Via
AccessWire
Exposures
Product Safety
SPAC Targeting AI Medical Therapeutics and Diagnostics; (NASDAQ: JUPW) Jupiter Wellness Sponsors Jupiter Wellness Acquisition
November 03, 2021
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Jupiter Wellness Sponsors Jupiter Wellness Acquisition Corp SPAC Targeting AI Medical Therapeutics and Diagnostics
November 03, 2021
AI in medicine is projected to grow 18X from 2018 through 2025 to $35 billion JUPITER, FL / ACCESSWIRE / November 3, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced that it has filed a...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300. Treatment of First Degree Burns: Jupiter Wellness, Inc. (NASDAQ: JUPW)
October 19, 2021
Via
Get News
Exposures
Product Safety
Jupiter Wellness Announces First Patient Dosing for Double-Blinded Placebo Controlled Trial of JW-300 for the Treatment of First Degree Burns
October 19, 2021
JUPITER, FL / ACCESSWIRE / October 19, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing a cannabinoid receptor agonist for the treatment of first degree burns, announced...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
NASDAQ Company in the Multi-Billion Dollar Market Treating Skin Disorders Including Skin Cancer: Jupiter Wellness, Inc. (NASDAQ: JUPW)
October 07, 2021
Via
Get News
Jupiter Wellness Provides Shareholder Update on Multiple Clinical & Commercial Milestones
October 07, 2021
JUPITER, FL / ACCESSWIRE / October 7, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today provided an update on its advancing clinical programs and commercial progress. Commercial: Photocil™ to Launch...
From
Jupiter Wellness, Inc.
Via
AccessWire
Exposures
Product Safety
Jupiter Wellness Announces Multi-Year Extension of Endorsement Agreement with Pro Golfer Ernie Els
September 08, 2021
Pro Golf Hall of Fame Legend Extends Endorsement of CaniSun Suncare Products JUPITER, FL / ACCESSWIRE / September 8, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a developer of enhanced skin care...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Biotech Requests Pre-IND Meeting with the US FDA: Jupiter Wellness: NASDAQ: JUPW JW-100 Clinical Program Treatment for Mild to Moderate Eczema
August 23, 2021
Via
Get News
Exposures
Product Safety
Jupiter Wellness Submitted a Pre-IND Meeting Request with the US FDA for its Proposed Clinical Program of JW-100 as a Treatment for Mild to Moderate Eczema
August 23, 2021
Following receipt of a Pre-Assignment number from the FDA Jupiter Wellness requests Pre-IND meeting JUPITER, FL / ACCESSWIRE / August 23, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a developer of...
From
Jupiter Wellness, Inc.
Via
AccessWire
Exposures
Product Safety
Big update for NASDAQ Biotech Jupiter Wellness: NASDAQ: JUPW Applies for IND number from the US Food & Drug Administration
August 16, 2021
Via
Get News
Jupiter Wellness Applies for IND number from the US Food and Drug Administration
August 16, 2021
Following positive results from the JW-100 investigator initiated trials for Eczema, Jupiter Wellness to commence US FDA program JUPITER, FL / ACCESSWIRE / August 16, 2021 / Jupiter Wellness, Inc....
From
Jupiter Wellness, Inc.
Via
AccessWire
Exposures
Product Safety
Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW).
July 26, 2021
NEW YORK, NY / ACCESSWIRE / July 26, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW)....
From
Aegis Capital Corp.
Via
AccessWire
Topics
Retirement
Exposures
Pension
Jupiter Wellness Closes $32.5 Million Underwritten Public Offering of Common Stock and Warrants
July 26, 2021
JUPITER, FL / ACCESSWIRE / July 26, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the closing of an underwritten public offering (the "Offering") of 11,066,258 shares...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Jupiter Wellness Prices $32.5 Million Underwritten Public Offering of Common Stock and Warrants
July 21, 2021
JUPITER, FL / ACCESSWIRE / July 21, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the pricing of an underwritten public offering (the "Offering") of 11,066,258 shares...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Strong Alignments and Sales for Biotech Jupiter Wellness on the NASDAQ: JUPW signs multi-year agreement with Rigour Int. for China, Hong Kong, Korea & S.E. Asian Markets
July 19, 2021
Via
Get News
Jupiter Wellness Announces Multi-Year Distribution Agreement with Rigour International for Expansion in Asia
July 19, 2021
JUPITER, FL / ACCESSWIRE / July 19, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a multi-year agreement with Rigour International LLC as the exclusive authorized distributor of Jupiter...
From
Jupiter Wellness, Inc.
Via
AccessWire
Jupiter Wellness Announces Appointment of Dr. Andy Goren to Scientific Advisory Board
July 15, 2021
JUPITER, FL / ACCESSWIRE / July 15, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced that Dr Andy Goren has been appointed to its Scientific Advisory Board. Dr. Andy Goren has more than...
From
Jupiter Wellness, Inc.
Via
AccessWire
Exposures
COVID-19
Biotech Star Jupiter Wellness on the NASDAQ: JUPW Initiates Head-to-Head Trial Comparing JW-100 and Pfizer’s: PFE Eucrisa® for the Treatment of Eczema
July 13, 2021
Via
Get News
Jupiter Wellness Announces initiation of Head-to-Head Trial Comparing JW-100 and Eucrisa(R) for the Treatment of Mild-to-Moderate Eczema
July 13, 2021
JUPITER, FL / ACCESSWIRE / July 13, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a head-to-head trial comparing JW-100 lotion with Eucrisa crisaborole ointment 2% for the treatment of...
From
Jupiter Wellness, Inc.
Via
AccessWire
Jupiter Wellness Licenses Photocil(TM), a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis and Atopic Dermatitis
July 09, 2021
*Photo-Therapy in a tub JUPITER, FL / ACCESSWIRE / July 9, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced they have entered into an exclusive agreement to license Photocil™, a novel...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Jupiter Wellness an Emerging NASDAQ: JUPW: Licenses Photocil™, a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis & Atopic Dermatitis
July 09, 2021
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
FDA Filing expected this Q3 for NASDAQ Company’s JW-100 treatment for Eczema; Jupiter Wellness, Inc. (NASDAQ: JUPW)
June 23, 2021
Via
Get News
Exposures
Product Safety
FDA Filing expected in Q3 for NASDAQ Company’s JW-100 treatment for Eczema; Jupiter Wellness, Inc. (NASDAQ: JUPW)
June 22, 2021
FDA Filing expected in Q3 for NASDAQ Company’s JW-100 treatment for Eczema; Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via
EIN Presswire
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Results of Clinical Study Showing That JW 100 Significantly Reduces ISGA Score in Atopic Dermatitis (AD) Published
June 22, 2021
https://pubmed.ncbi.nlm.nih.gov/34056830/ JUPITER, FL / ACCESSWIRE / June 22, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced the publication of clinical study results to investigate the...
From
Jupiter Wellness, Inc.
Via
AccessWire
Exposures
Product Safety
NASDAQ Co Developing Therapeutic & Wellness Products for Skin Disorders, Diseases & Cancers; Jupiter Inc (NASDAQ: JUPW)
June 17, 2021
NASDAQ Co Quickly Developing Therapeutic & Wellness Products for Skin Disorders, Diseases and Cancers; Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via
EIN Presswire
Topics
Intellectual Property
Regulatory Compliance
Exposures
Intellectual Property
Legal
Product Safety
Jupiter Wellness Licenses Patents for the Treatment of Contact Dermatitis
June 17, 2021
JUPITER, FL / ACCESSWIRE / June 17, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a licensing agreement for two patents covering the use of Aspartame for the treatment of Contact...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments
April 29, 2021
Four Indications in Clinical Development JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and...
From
Jupiter Wellness, Inc.
Via
AccessWire
Exposures
Product Safety
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.